Gradient Denervation Technologies
Paris
About Gradient Denervation Technologies
Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2023)
- Website: gradientdenervation.com
Industries & Categories
Biotechnology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/gradient-denervation-technologies-34448 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.